Gland Pharma’s Q2FY22 Revenue grew by 30% with Net Profit growth of 38%
Hyderabad, October 23, 2021 (GPN): Gland Pharma Limited (BSE: 543245 I NSE: GLAND), a generic injectable focused pharmaceutical company, today announced its financial results for the second quarter and half year ended September 30, 2021….